InvestorPlace - Stock Market News, Stock Advice & Trading Tips Since the bull market began in November 2022, growth stocks have outperformed ...

The NCI-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) offers a better approach: an outpatient cancer ...

Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics First Quarter 2024 Earnings Call. [Operator ...

Argenica Therapeutics (ASX:AGN), has announced fabulous results from a pilot study assessing the efficacy of lead drug ...

May 7, 2024 Agenus Inc. beats earnings expectations. Reported EPS is $-3.04104, expectations were $-3.1. AGEN isn't one of ...

The difference between playing the stock market and the horses is that one of the horses must win.” - Joey Adams ...

As per the combined projections of four brokerages, there's a possibility of the net profit for the fourth quarter surging by ...

Cipla's US sales likely to surge in Q4, driven by the contribution from Revlimid, along with a stable market share in ...

Here is how Bristol Myers performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Recent LOE Products- Abraxane- U.S ...

Good afternoon, everyone, and welcome to the Panbela Therapeutics first-quarter 2024 earnings call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the ...

469. Patrick Soon-Shiong, MD, $5.8 billion, was a practicing physician before inventing the cancer medication Abraxane. He attended the University of British Columbia in Vancouver and the University ...